These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

125 related articles for article (PubMed ID: 8342923)

  • 1. Prevention of thrombosis by topical application of tissue factor pathway inhibitor in a rabbit model of vascular trauma.
    Khouri RK; Koudsi B; Kaiding F; Ornberg RL; Wun TC
    Ann Plast Surg; 1993 May; 30(5):398-402; discussion 402-4. PubMed ID: 8342923
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Topical tissue factor pathway inhibitor improves free-flap survival in a model simulating free-flap errors.
    Ozbeck MR; Brown DM; Deune EG; Lantieri LA; Kania NM; Pasia EN; Cooley BC; Wun TC; Khouri RK
    J Reconstr Microsurg; 1995 May; 11(3):185-8. PubMed ID: 7650643
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Prevention of microvascular thrombosis by topical application of recombinant tissue factor pathway inhibitor.
    Lantieri LA; Ozbek MR; Deune EG; Ornberg RL; Brown DM; Chung SH; Wun TC; Cooley BC; Khouri RK
    Plast Reconstr Surg; 1996 Mar; 97(3):587-94. PubMed ID: 8596790
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparative study on the use of anticoagulants heparin and recombinant hirudin in a rabbit traumatic anastomosis model.
    Fu K; Izquierdo R; Walenga JM; Fareed J
    Thromb Res; 1995 Jun; 78(5):421-8. PubMed ID: 7660358
    [TBL] [Abstract][Full Text] [Related]  

  • 5. A blinded trial of local recombinant tissue factor pathway inhibitor versus either local or systemic heparin in a vein bypass model.
    Rapp JH; Pan XM; Ghermay A; Gazetas P; Brady SE; Reilly LM
    J Vasc Surg; 1997 Apr; 25(4):726-9. PubMed ID: 9129630
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Localization of topically applied TFPI binding sites in an intimectomized microvessel.
    Ornberg RL; Deune EG; Ozbek MR; Wun TC; Khouri RK
    Thromb Haemost; 1995 Jan; 73(1):55-8. PubMed ID: 7740496
    [TBL] [Abstract][Full Text] [Related]  

  • 7. The efficacy of tissue factor pathway inhibitor (TFPI) as topically applied antithrombotic agent.
    Aagaard S; Hjortdal VE; Barker JH
    APMIS Suppl; 2003; (109):102-7. PubMed ID: 12874959
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Effects of enoxaparin, standard heparin, and streptokinase on the patency of anastomoses in severely crushed arteries.
    Chen LE; Seaber AV; Korompilias AV; Urbaniak JR
    Microsurgery; 1995; 16(10):661-5. PubMed ID: 8676728
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Topically administered macromolecular heparin proteoglycans inhibit thrombus growth in microvascular anastomoses.
    Olsson E; Asko-Seljavaara S; Lassila R
    Thromb Haemost; 2002 Feb; 87(2):245-51. PubMed ID: 11858484
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Recombinant full-length tissue factor pathway inhibitor (TFPI) prevents thrombus formation and rethrombosis after lysis in a rabbit model of jugular vein thrombosis.
    Kaiser B; Fareed J
    Thromb Haemost; 1996 Oct; 76(4):615-20. PubMed ID: 8903005
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Modified crush-avulsion anastomosis model on the rat femoral vein.
    Fu K; Izquierdo R; Hubbard T; Fareed J
    Microsurgery; 1995; 16(8):536-41. PubMed ID: 8538430
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Inhibition of microsurgical thrombosis by the platelet glycoprotein IIb/IIIa antagonist SR121566A.
    Ching S; Thoma A; Monkman S; Kelton JG
    Plast Reconstr Surg; 2003 Jul; 112(1):177-85. PubMed ID: 12832891
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Combination of a brief irrigation with tissue factor pathway inhibitor (TFPI) and adenovirus-mediated local TFPI gene transfer additively reduces neointima formation in balloon-injured rabbit carotid arteries.
    Atsuchi N; Nishida T; Marutsuka K; Asada Y; Kamikubo Y; Takeshita A; Ueno H
    Circulation; 2001 Jan; 103(4):570-5. PubMed ID: 11157724
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Topical heparin enhances patency in a rat model of arterial thrombosis.
    Braam MJ; Cooley BC; Gould JS
    Ann Plast Surg; 1995 Feb; 34(2):148-51; discussion 151-3. PubMed ID: 7741432
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Prevention of experimental arterial thrombosis by topical administration of active site-inactivated factor VIIa.
    Arnljots B; Ezban M; Hedner U
    J Vasc Surg; 1997 Feb; 25(2):341-6. PubMed ID: 9052569
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Topically applied tissue factor pathway inhibitor reduced intimal thickness of small arterial autografts in rabbits.
    Sun LB; Utoh J; Moriyama S; Tagami H; Okamoto K; Kitamura N
    J Vasc Surg; 2001 Jul; 34(1):151-5. PubMed ID: 11436089
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Topical application of low molecular weight heparin in a rabbit traumatic anastomosis model.
    Fu K; Izquierdo R; Vandevender D; Warpeha RL; Wolf H; Fareed J
    Thromb Res; 1997 Jun; 86(5):355-61. PubMed ID: 9211626
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Does glycosylation influence the experimental antithrombotic effect of a two-domain tissue factor pathway inhibitor?
    Holst J; Lindblad B; Nordfang O; Ostergaard PB; Hedner U
    Haemostasis; 1996; 26(1):23-30. PubMed ID: 8698275
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Active site-inactivated factor VIIa prevents thrombosis without increased surgical bleeding: topical and intravenous administration in a rat model of deep arterial injury.
    Söderström T; Hedner U; Arnljots B
    J Vasc Surg; 2001 May; 33(5):1072-9. PubMed ID: 11331851
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Inhibition of microarterial thrombosis by activated protein C in a rabbit model.
    Arnljots B; Bergqvist D; Dahlbäck B
    Thromb Haemost; 1994 Sep; 72(3):415-20. PubMed ID: 7855793
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.